124 related articles for article (PubMed ID: 19770372)
1. Low initial human papilloma viral load implicates worse prognosis in patients with uterine cervical cancer treated with radiotherapy.
Kim JY; Park S; Nam BH; Roh JW; Lee CH; Kim YH; Shin HJ; Lee SK; Kong SY; Seong MW; Han TJ; Lee MY; Cho KH; Park SY
J Clin Oncol; 2009 Oct; 27(30):5088-93. PubMed ID: 19770372
[TBL] [Abstract][Full Text] [Related]
2. High human papillomavirus oncogene mRNA expression and not viral DNA load is associated with poor prognosis in cervical cancer patients.
de Boer MA; Jordanova ES; Kenter GG; Peters AA; Corver WE; Trimbos JB; Fleuren GJ
Clin Cancer Res; 2007 Jan; 13(1):132-8. PubMed ID: 17200347
[TBL] [Abstract][Full Text] [Related]
3. Clinical effect of human papillomavirus genotypes in patients with cervical cancer undergoing primary radiotherapy.
Wang CC; Lai CH; Huang HJ; Chao A; Chang CJ; Chang TC; Chou HH; Hong JH
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1111-20. PubMed ID: 20231068
[TBL] [Abstract][Full Text] [Related]
4. Role of human papillomavirus genotype in prognosis of early-stage cervical cancer undergoing primary surgery.
Lai CH; Chang CJ; Huang HJ; Hsueh S; Chao A; Yang JE; Lin CT; Huang SL; Hong JH; Chou HH; Wu TI; Huang KG; Wang CC; Chang TC
J Clin Oncol; 2007 Aug; 25(24):3628-34. PubMed ID: 17704412
[TBL] [Abstract][Full Text] [Related]
5. Differences in human papillomavirus type may influence clinical outcome in early stage cervical cancer.
Dahlgren L; Erlandsson F; Lindquist D; Silfverswärd C; Hellström AC; Dalianis T
Anticancer Res; 2006; 26(2A):829-32. PubMed ID: 16619476
[TBL] [Abstract][Full Text] [Related]
6. Factors predicting the persistence of genital human papillomavirus infections and PAP smear abnormality in HIV-positive and HIV-negative women during prospective follow-up.
Branca M; Garbuglia AR; Benedetto A; Cappiello T; Leoncini L; Migliore G; Agarossi A; Syrjänen K;
Int J STD AIDS; 2003 Jun; 14(6):417-25. PubMed ID: 12816671
[TBL] [Abstract][Full Text] [Related]
7. Determination of HPV type 16 and 18 viral load in cervical smears of women referred to colposcopy.
Carcopino X; Henry M; Benmoura D; Fallabregues AS; Richet H; Boubli L; Tamalet C
J Med Virol; 2006 Aug; 78(8):1131-40. PubMed ID: 16789021
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of antibodies to human papillomavirus as prognostic markers in cervical cancer patients.
Silins I; Avall-Lundqvist E; Tadesse A; Jansen KU; Stendahl U; Lenner P; Zumbach K; Pawlita M; Dillner J; Frankendal B
Gynecol Oncol; 2002 May; 85(2):333-8. PubMed ID: 11972397
[TBL] [Abstract][Full Text] [Related]
9. Persistence of human papillomavirus infection as a predictor for recurrence in carcinoma of the cervix after radiotherapy.
Nagai Y; Toma T; Moromizato H; Maehama T; Asato T; Kariya K; Kanazawa K
Am J Obstet Gynecol; 2004 Dec; 191(6):1907-13. PubMed ID: 15592271
[TBL] [Abstract][Full Text] [Related]
10. Adenocarcinoma of the uterine cervix: prognostic significance of clinicopathologic parameters, flow cytometry analysis and HPV infection.
Dabić MM; Nola M; Tomicić I; Dotlić S; Petrovecki M; Jukić S
Acta Obstet Gynecol Scand; 2008; 87(3):366-72. PubMed ID: 18307079
[TBL] [Abstract][Full Text] [Related]
11. Detection and quantitation of human papillomavirus DNA in primary tumour and lymph nodes of patients with early stage cervical carcinoma.
Chan PK; Yu MM; Cheung TH; To KF; Lo KW; Cheung JL; Tong JH
J Clin Virol; 2005 Jul; 33(3):201-5. PubMed ID: 15911441
[TBL] [Abstract][Full Text] [Related]
12. HPV-18 is a poor prognostic factor, unlike the HPV viral load, in patients with stage IB-IIA cervical cancer undergoing radical hysterectomy.
Kang WD; Kim CH; Cho MK; Kim JW; Cho HY; Kim YH; Choi HS; Kim SM
Gynecol Oncol; 2011 Jun; 121(3):546-50. PubMed ID: 21334052
[TBL] [Abstract][Full Text] [Related]
13. Human papillomavirus type distribution in cervical cancer in Delhi, India.
Bhatla N; Dar L; Patro AR; Kriplani A; Gulati A; Verma K; Broor S; Shah KV; Gravitt PE
Int J Gynecol Pathol; 2006 Oct; 25(4):398-402. PubMed ID: 16990719
[TBL] [Abstract][Full Text] [Related]
14. HPV presence precedes abnormal cytology in women developing cervical cancer and signals false negative smears.
Zielinski GD; Snijders PJ; Rozendaal L; Voorhorst FJ; van der Linden HC; Runsink AP; de Schipper FA; Meijer CJ
Br J Cancer; 2001 Aug; 85(3):398-404. PubMed ID: 11487272
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and viral load of oncogenic human papillomavirus types associated with cervical carcinoma in a population of North Italy.
Broccolo F; Chiari S; Piana A; Castiglia P; Dell'Anna T; Garcia-Parra R; Maneo A; Villa A; Leone EB; Perego P; Maida A; Mangioni C; Cocuzza CE
J Med Virol; 2009 Feb; 81(2):278-87. PubMed ID: 19107971
[TBL] [Abstract][Full Text] [Related]
16. Determination of human papillomavirus (HPV) load and type in high-grade cervical lesions surgically resected from HIV-infected women during follow-up of HPV infection.
Lillo FB; Lodini S; Ferrari D; Stayton C; Taccagni G; Galli L; Lazzarin A; Uberti-Foppa C
Clin Infect Dis; 2005 Feb; 40(3):451-7. PubMed ID: 15668870
[TBL] [Abstract][Full Text] [Related]
17. Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention.
Castellsagué X; Díaz M; de Sanjosé S; Muñoz N; Herrero R; Franceschi S; Peeling RW; Ashley R; Smith JS; Snijders PJ; Meijer CJ; Bosch FX;
J Natl Cancer Inst; 2006 Mar; 98(5):303-15. PubMed ID: 16507827
[TBL] [Abstract][Full Text] [Related]
18. Bcl2 and human papilloma virus 16 as predictors of outcome following concurrent chemoradiation for advanced oropharyngeal cancer.
Nichols AC; Finkelstein DM; Faquin WC; Westra WH; Mroz EA; Kneuertz P; Begum S; Michaud WA; Busse PM; Clark JR; Rocco JW
Clin Cancer Res; 2010 Apr; 16(7):2138-46. PubMed ID: 20233885
[TBL] [Abstract][Full Text] [Related]
19. Persistent human papillomavirus DNA is associated with local recurrence after radiotherapy of uterine cervical cancer.
Song YJ; Kim JY; Lee SK; Lim HS; Lim MC; Seo SS; Kang S; Lee DO; Park SY
Int J Cancer; 2011 Aug; 129(4):896-902. PubMed ID: 21064095
[TBL] [Abstract][Full Text] [Related]
20. Human papillomavirus (HPV) test and PAP smear as predictors of outcome in conservatively treated adenocarcinoma in situ (AIS) of the uterine cervix.
Costa S; Negri G; Sideri M; Santini D; Martinelli G; Venturoli S; Pelusi C; Syrjanen S; Syrjanen K; Pelusi G
Gynecol Oncol; 2007 Jul; 106(1):170-6. PubMed ID: 17481701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
